HENDERSON MOLLY (CFO and CBO) received a stock award from PHATHOM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/31/2024ACC: 0000950170-24-067548
Officer· CFO and CBO
Since Apr 2022
+7.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
7.50K acquired
Non-Derivative Transactions1
Common Stoock
Direct
Shares
+7.50K
Price / share
—
Trade value
—
% of position
7.9%
5/31/2024
95.26K→102.76K
Total
Net shares
+7.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stoock Direct | 5/31/2024 | A · Award | +7.50K | — | — | 7.9% | 95.26K | 102.76K |
| Total | +7.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.91K
Total
1.91K indirect1.91K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.91K | Indirect |
| Total | 1.91K | 1.91K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported